The 2024 diagnostic criteria for primary sclerosing cholangitis

Itaru Naitoh, Hiroyuki Isayama, Nobuhisa Akamatsu, Suguru Mizuno, Toshio Fujisawa, Nobuhiro Nakamoto, Yousuke Nakai, Shuichiro Umetsu, Mitsuyoshi Suzuki, Shintaro Yagi, Hironori Haga, Kenji Notohara, Katsuhiro Sano, Susumu Tazuma, Takahiro Nakazawa, Atsushi Tanaka J Gastroenterol (2025) 60:1221–1231 https://doi.org/10.1007/s00535-025-02265 Πατήστε ΕΔΩ για να δείτε την περίληψη του άρθρου

Λεπτομέρειες

Impact of first and further decompensation in patients with compensated ACLD due to MASLD

Grazia Pennisi1,*,†, Gabriele Di Maria2,†, Vincent Wai-Sun Wong3, Victor de Ledinghen4, Giada Sebastiani5, Mauro Viganò6, Anna Ludovica Fracanzani7,8, Luca Miele9, Elisabetta Bugianesi10, Mattias Ekstedt11, Roberta D’Ambrosio12, Federico Ravaioli13,14, Filippo Schepis15, Fabio Marra16, Alessio Aghemo17,18, Gianluca Svegliati-Baroni19, Marcello Persico20, Luca Valenti7,21, Annalisa Berzigotti22, Jacob George23, Angelo Armandi10, Patrik Nasr11, Stergios Kechagias11, Antonio Liguori9, Dario Saltini15, Yuly…

Λεπτομέρειες

The burden of extrahepatic organ failures in European patients with cirrhosis

Wenyi G, Thierry A, Lise Lotte G, Salvatore P, William B, Wim L, Minneke JC, Paolo A, Trebicka Jonel T, Richard M Hepatology Communications, December 2025 DOI: 10.1097/HC9.0000000000000832 Πατήστε ΕΔΩ για να δείτε την περίληψη του άρθρου

Λεπτομέρειες

Linerixibat in patients with primary biliary cholangitisand cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

Hirschfield G et al , doi: 10.1016/S2468-1253(25)00192-X Lancet Gastroenterol Hepatol 2025 Oct 28:S2468-1253(25)00192-X. Πατήστε ΕΔΩ για να δείτε την περίληψη του άρθρου

Λεπτομέρειες